Cut-Price Generics Set To Challenge Boehringer’s Nintedanib In India

 
• By Anju Ghangurde
  
Lungs
India Competition Arrives For Boehringer's Nintedanib • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia